AMICUS THERAPEUTICS, INC. — Director's Dealing 2018

May 18, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AMICUS THERAPEUTICS INC (FOLD)
CIK: 0001178879
Period of Report: 2018-05-16

Reporting Person: MCGLYNN MARGARET G (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-05-16	Common Stock	M	10000	$3.32	Acquired	25814	Direct
2018-05-16	Common Stock	S	10000	$16.00	Disposed	15814	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-05-16	Stock Options (right to buy)	$3.32	M	10000	Disposed	2020-03-16	Common Stock (10000)	Direct

Footnotes

F1: The exercise of stock options and subsequent sale of common stock were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 9, 2018.

F2: All of the options were fully vested and exercisable as of May 16, 2018.